The relationship between myopia and conjunctival-scleral geometry
September 30, 2021
Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Refractive
FDA-approved eye drops target presbyopia patients
November 14, 2021
Cathleen McCabe, MD, discusses VUITY, the first and only FDA-approved eye drop to treat age-related blurry near vision, and how it provides opportunities for patients looking for spectacle independence.
Highlighting results from first FDA-reported study for treatment of presbyopia
September 27, 2021
George O. Waring IV, MD, FACS, discusses the latest results from the GEMINI 1 clinical trial (by Allergan, an Abbvie company) of AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia.
Study targets utility of epithelial thickness mapping
September 17, 2021
Investigators examine usefulness in refractive surgery evaluations.
Presbyopia-correcting IOL improves vision for patients
September 08, 2021
Early experience with next-generation lens engenders positive perception.
Analyzing GEMINI 1 clinical trial results of presbyopia eye drop
August 30, 2021
George O. Waring IV, MD, FACS, discusses the latest results from the GEMINI 1 clinical trial of AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia.
Examining 10-year postop data on epi-off CXL for keratoconus, ectasia
August 28, 2021
Steven Greenstein, MD, reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients.
FDA grants clearance for myopia device
August 10, 2021
According to Oculus, its Myopia Master saves space and can be mounted on a workstation or an ophthalmic table. The software is operated directly via an inbuilt display.
Four tips for growing a proactive practice
August 10, 2021
Taking control of a practice’s future with investment, creative thinking
Outcomes of LASIK utilising new topography-integrated aberrometer
July 25, 2021
Colman R. Kraff, MD, shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio for the treatment of patients with hyperopia and myopia.